Home/Filings/4/0001628280-24-047994
4//SEC Filing

Foster Karen A. 4

Accession 0001628280-24-047994

CIK 0000834365other

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 6:38 PM ET

Size

5.1 KB

Accession

0001628280-24-047994

Insider Transaction Report

Form 4
Period: 2024-11-12
Foster Karen A.
Chief Quality and Operations
Transactions
  • Sale

    Common Stock

    2024-11-12$26.34/sh66$1,738157,225 total
Footnotes (1)
  • [F1]The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Issuer

BIOLIFE SOLUTIONS INC

CIK 0000834365

Entity typeother

Related Parties

1
  • filerCIK 0001683151

Filing Metadata

Form type
4
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 6:38 PM ET
Size
5.1 KB